Work

A phase I study of TRC105 (anti-CD105 [endoglin] antibody) in metastatic castration-resistant prostate cancer (mCRPC).

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.5_suppl.117

Authors: Fatima H Karzai, Andrea Borghese Apolo, David E. Adelberg, Ravi Amrit Madan, James L. Gulley, Philip M. Arlen, Howard L. Parnes, Ann Pierpoint, David R. Kohler, Douglas K. Price, Seth M Steinberg, Jane B. Trepel, William Douglas Figg, William L. Dahut

Institutions: National Institutes of Health, National Cancer Institute

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4249254077

Cites:

Cited by: 2

Related to: 10